At present, value of the global safety needles market is estimated to be s worth US$ 3,752.2 Mn, and it is estimated to reach US$ 7,765.7 Mn by 2027-end, witnessing a CAGR of 6.9% during this forecast period. The growing focus on utilization of prefilled syringes for treatment of several ailments is fuelling the demand for safety needles across the globe. Factors such as changing lifestyle habits, exposure to hormones and infection by HCV are expected to result in gynaecological cancers. Rising incidence rate of gynaecological cancers, coupled with higher presence of lower-back problems in regions such as the US are driving the demand for spine needles and other types of safety needles.
Rising Focus on Use of Prefilled Syringes Fuelling the Demand
The sole purpose of designing safety needles was to avoid needlestick injuries while collecting fluids and delivering drugs to the body. The key players of global market for safety needles are enhancing their product portfolio by focusing on production of innovative needles with safety features.
Request a report sample to gain comprehensive insights @
https://www.futuremarketinsights.com/reports/sample/rep-gb-2029
These players include B. Braun Melsungen AG, Novo Nordisk A/S, Medtronic, and Becton, Dickinson and Company. Becton, Dickinson and Company holds its dominance in the overall market with around 50% share, followed by Medtronic and Novo Nordisk AS. Future Market Insights’ recent report profiles Smith Medical and Argon medical Inc. as emerging safety needle manufacturers, while Terumo Medical Corporation and Boston Scientific Inc. are recognised as mid-level players in the global safety needles market.
Trends Observed in the Global Safety Needles Market
Leading companies are participating in campaigns in co-ordination with governments of several economies for raising awareness about unsafe use of reusable needles among patients. Increasing prevalence of HIV & blood-borne diseases, owing to needle injuries, has also urged the companies for development of needles with enhanced safety features.
Key findings from FMI’s Report Include
APEJ – Fastest-Growing Safety Needles Market in World
Around 24% market share is estimated to be held by Western Europe by the end of 2027, while APEJ is expected to register fastest growth in the global market for safety needles. In contrast, Eastern Europe is poised to depict a sluggish growth during the forecast period, while North America is will remain the outright dominant region in the global market for safety needles.
https://www.futuremarketinsights.com/customization-available/rep-gb-2029
Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of the Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favour the market growth in various segments based on Source, Application, Sales Channel and End-Use over the next 10-years.
Future Market Insights Inc. Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware – 19713, USA T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings. The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2022 PHARMIWEB.COM LIMITED, rights reserved by the relevant holders.
You are leaving PharmiWeb.com
Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites.
ABOUT THIRD PARTY LINKS ON OUR SITE
PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave the PharmiWeb.com website and will be redirected to another site. These sites are not under the control of PharmiWeb.com.
PharmiWeb.com is not responsible for the content of linked third party websites. We are not an agent for these third parties nor do we endorse or guarantee their products. We make no representation or warranty regarding the accuracy of the information contained in the linked sites. We suggest that you always verify the information obtained from linked websites before acting upon this information.
Also, please be aware that the security and privacy policies on these sites may be different than PharmiWeb.com policies, so please read third party privacy and security policies closely.
If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.